Emerging synthetic biology tools for engineering mammalian cell systems and expediting cell line development

Current Opinion in Chemical Engineering

Volumn 1, Issue 4, 2012, Pages 403-410

  Lanza, Amanda M ^a   Cheng, Joseph K ^a   Alper, Hal S ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; MAMMALS;

CELL STABILITY; DEVELOPMENT PROCESS; MAMMALIAN CELLS; MICROBIAL CELLS; PATHWAY ENGINEERINGS; REGULATORY ELEMENTS; SITE-SPECIFIC; SYNTHETIC BIOLOGY;

CELL ENGINEERING;

EID: 84874111403     PISSN: None     EISSN: 22113398     Source Type: Journal    
DOI: 10.1016/j.coche.2012.09.005     Document Type: Review

References (77)

1. Wurm FM: Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 2004, 22:1393-1398. (Pubitemid 39482858)
2. The Truly Staggering Cost of Inventing New Drugs - The Print Version on World Wide Web URL: http://www.forbes.com/sites/matthewherper/2012/02/22/the- truly-staggering-cost-ofinventing-new-drugs-the-print-version/.
3. Dietmair S, Nielsen LK, Timmins NE: Mammalian cells as biopharmaceutical production hosts in the age of omics. Biotechnol J 2011, 7:75-89.
4. Kantardjieff A, Nissom PM, Chuah SH, Yusufi F, Jacob NM, Mulukutla BC, Yap M, Hu WS: Developing genomic platforms for Chinese hamster ovary cells. Biotechnol Adv 2009, 27:1028-1035.
5. Gersbach CA, Gaj T, Gordley RM, Mercer AC, Barbas CF 3rd: Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase. Nucleic Acids Res 2011, 39:7868-7878.
6. Sun N, Abil Z, Zhao H: Recent advances in targeted genome engineering in mammalian systems. Biotechnol J 2012.
7. Kramer O, Klausing S, Noll T: Methods in mammalian cell line engineering: from random mutagenesis to sequence-specific approaches. Appl Microbiol Biotechnol 2010, 88:425-436.
8. Silva G, Poirot L, Galetto R, Smith J, Montoya G, Duchateau P, Paques F: Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Curr Gene Ther 2010, 11:11-27.
9. Kennard ML, Goosney DL, Monteith D, Zhang L, Moffat M, Fischer D, Mott J: The generation of stable, high MAb expressing CHO cell lines based on the artificial chromosome expression (ACE) technology. Biotechnol Bioeng 2009, 104:540-553.
10. Kim JY, Kim YG, Lee GM: CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol 2011, 93:917-930.
11. Rita Costa A, Elisa Rodrigues M, Henriques M, Azeredo J, Oliveira R: Guidelines to cell engineering for monoclonal antibody production. Eur J Pharm Biopharm 2009, 74:127-138.
12. Nern A, Pfeiffer BD, Svoboda K, Rubin GM: Multiple new sitespecific recombinases for use in manipulating animal genomes. Proc Natl Acad Sci USA 2011, 108:14198-14203.
13. Xie F, Ma Q, Jiang S, Ren Z, Wang J, Huang S, Zeng F, Zeng Y: Adjusting the attB site in donor plasmid improves the efficiency of PhiC31 integrase system. DNA Cell Biol 2012, 31:1335-1340.
14. Patsch C, Kesseler D, Edenhofer F: Genetic engineering of mammalian cells by direct delivery of FLP recombinase protein. Methods 2011, 53:386-393.
15. Takata Y, Kondo S, Goda N, Kanegae Y, Saito I: Comparison of efficiency between FLPe and Cre for recombinase-mediated cassette exchange in vitro and in adenovirus vector production. Genes Cells 2011, 16:765-777.
16. Yamaguchi S, Kazuki Y, Nakayama Y, Nanba E, Oshimura M, Ohbayashi T: A method for producing transgenic cells using a multi-integrase system on a human artificial chromosome vector. PLoS ONE 2011, 6:e17267.
17. Lanza AM, Dyess TJ, Alper HS: Using the Cre/lox system for targeted integration into the human genome: loxFAS-loxP pairing and delayed introduction of Cre DNA improve gene swapping efficiency. Biotechnol J 2012, 7:898-908.
18. Grizot S, Smith J, Daboussi F, Prieto J, Redondo P, Merino N, Villate M, Thomas S, Lemaire L, Montoya G et al.: Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease. Nucleic Acids Res 2009, 37:5405-5419.
19. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD: Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010, 11:636-646.
20. Liu P-Q, Chan EM, Cost GJ, Zhang L, Wang J, Miller JC, Guschin DY, Reik A, Holmes MC, Mott JE et al.: Generation of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases. Biotechnol Bioeng 2010, 106:97-105.
21. Malphettes L, Freyvert Y, Chang J, Liu PQ, Chan E, Miller JC, Zhou Z, Nguyen T, Tsai C, Snowden AW et al.: Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies. Biotechnol Bioeng 2010, 106:774-783.
22. Mussolino C, Cathomen T: TALE nucleases: tailored genome engineering made easy. Curr Opin Biotechnol 2012 http://dx.doi.org/10.1016/j.copbio.2012.01.013.
23. Briggs AW, Rios X, Chari R, Yang L, Zhang F, Mali P, Church GM: Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res 2012, 40:e117.
24. Miller JC, Tan S, Qiao G, Barlow KA, Wang J, Xia DF, Meng X, Paschon DE, Leung E, Hinkley SJ et al.: A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 2010, 29:143-148.
25. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC et al.: Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011, 29:731-734.
26. Shibata Y, Kumar P, Layer R, Willcox S, Gagan JR, Griffith JD, Dutta A: Extrachromosomal microDNAs and chromosomal microdeletions in normal tissues. Science 2012, 336:82-86.
27. Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM: Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serumfree conditions. Nucleic Acids Res 2008, 36:e96.
28. Codamo J, Munro TP, Hughes BS, Song M, Gray PP: Enhanced CHO cell-based transient gene expression with the epi-CHO expression system. Mol Biotechnol 2011, 48:109-115.
29. Codamo J, Hou JJC, Hughes BS, Gray PP, Munro TP: Efficient mAb production in CHO cells incorporating PEI-mediated transfection, mild hypothermia and the co-expression of XBP-1. J Chem Technol Biotechnol 2011, 86:923-934.
30. Young E, Alper H: Synthetic biology: tools to design, build, and optimize cellular processes. J Biomed Biotechnol 2010, 2010:130781.
31. Khalil AS, Collins JJ: Synthetic biology: applications come of age. Nat Rev Genet 2010, 11:367-379.
32. Leonard E, Nielsen D, Solomon K, Prather KJ: Engineering microbes with synthetic biology frameworks. Trends Biotechnol 2008, 26:674-681.
33. Seo S, Kim S, Jung G: Synthetic regulatory tools for microbial engineering. Biotechnol Bioprocess Eng 2012, 17:1-7.
34. Siddiqui MS, Thodey K, Trenchard I, Smolke CD: Advancing secondary metabolite biosynthesis in yeast with synthetic biology tools. FEMS Yeast Res 2011, 12:144-170.
35. Melnikov A, Murugan A, Zhang X, Tesileanu T, Wang L, Rogov P, Feizi S, Gnirke A, Callan CG Jr, Kinney JB et al.: Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat Biotechnol 2012, 30:271-277.
36. Schlabach MR, Hu JK, Li M, Elledge SJ: Synthetic design of strong promoters. Proc Natl Acad Sci USA 2010, 107:2538-2543.
37. Patwardhan RP, Hiatt JB, Witten DM, Kim MJ, Smith RP, May D, Lee C, Andrie JM, Lee SI, Cooper GM et al.: Massively parallel functional dissection of mammalian enhancers in vivo. Nat Biotechnol 2012, 30:265-270.
38. Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, Liu X, Chen W, Xie M, Wang W, Hammond S et al.: The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 2011, 29:735-741.
39. Alper H, Fischer C, Nevoigt E, Stephanopoulos G: Tuning genetic control through promoter engineering. Proc Natl Acad Sci USA 2005, 102:12678-12683. (Pubitemid 41279425)
40. Blazeck J, Liu L, Redden H, Alper H: Tuning gene expression in Yarrowia lipolytica by a hybrid promoter approach. Appl Environ Microbiol 2012, 77:7905-7914.
41. Nevoigt E, Kohnke J, Fischer CR, Alper H, Stahl U, Stephanopoulos G: Engineering of promoter replacement cassettes for fine-tuning of gene expression in Saccharomyces cerevisiae. Appl Environ Microbiol 2006, 72:5266-5273.
42. Ferreira J, Peacock R, Lawhorn I, Wang C: Modulating ectopic gene expression levels by using retroviral vectors equipped with synthetic promoters. Syst Synth Biol 2012, 5:131-138.
43. Ferreira JP, Lawhorn IE, Peacock RW, Wang CL: Quantitative assessment of Ras over-expression via shotgun deployment of vectors utilizing synthetic promoters. Integr Biol (Camb) 2012, 4:108-114.
44. Magnusson T, Haase R, Schleef M, Wagner E, Ogris M: Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations. J Gene Med 2011, 13:382-391.
45. Tigges M, Fussenegger M: Recent advances in mammalian synthetic biology-design of synthetic transgene control networks. Curr Opin Biotechnol 2009, 20:449-460.
46. Mullick A, Xu Y, Warren R, Koutroumanis M, Guilbault C, Broussau S, Malenfant F, Bourget L, Lamoureux L, Lo R et al.: The cumate gene-switch: a system for regulated expression in mammalian cells. BMC Biotechnol 2006, 6:43.
47. Auslander D, Wieland M, Auslander S, Tigges M, Fussenegger M: Rational design of a small molecule-responsive intramer controlling transgene expression in mammalian cells. Nucleic Acids Res 2011, 39:e155.
48. Wieland M, Auslander D, Fussenegger M: Engineering of ribozyme-based riboswitches for mammalian cells. Methods 2012, 56:351-357.
49. Weber W, Lienhart C, Baba MD, Fussenegger M: A biotintriggered genetic switch in mammalian cells and mice. Metab Eng 2009, 11:117-124.
50. Ho SC, Bardor M, Feng H, Mariati, Tong YW, Song Z, Yap MG, Yang Y: IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines. J Biotechnol 2011, 157:130-139.
51. Mariati, Ho SC, Yap MG, Yang Y: Evaluating post-transcriptional regulatory elements for enhancing transient gene expression levels in CHO K1 and HEK293 cells. Protein Expr Purif 2009, 69:9-15.
52. Sun J, Li D, Hao Y, Zhang Y, Fan W, Fu J, Hu Y, Liu Y, Shao Y: Posttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy. DNA Cell Biol 2009, 28:233-240.
53. Zhang F, Frost AR, Blundell MP, Bales O, Antoniou MN, Thrasher AJ: A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. Mol Ther 2010, 18:1640-1649.
54. Boscolo S, Mion F, Licciulli M, Macor P, De Maso L, Brce M, Antoniou MN, Marzari R, Santoro C, Sblattero D: Simple scale-up of recombinant antibody production using an UCOE containing vector. N Biotechnol 2012, 29:477-484.
55. Nair AR, Jinger X, Hermiston TW: Effect of different UCOEpromoter combinations in creation of engineered cell lines for the production of Factor VIII. BMC Res Notes 2011, 4:178.
56. Haase R, Argyros O, Wong SP, Harbottle RP, Lipps HJ, Ogris M, Magnusson T, Vizoso Pinto MG, Haas J, Baiker A: pEPito: a significantly improved non-viral episomal expression vector for mammalian cells. BMC Biotechnol 2010, 10:20.
57. Araki Y, Hamafuji T, Noguchi C, Shimizu N: Efficient recombinant production in mammalian cells using a novel IR/MAR gene amplification method. PLoS ONE 2012, 7:e41787.
58. Lin N, Davis A, Bahr S, Borgschulte T, Achtien K, Kayser K: Profiling highly conserved microrna expression in recombinant IgG-producing and parental chinese hamster ovary cells. Biotechnol Prog 2011, 27:1163-1171.
59. Barron N, Kumar N, Sanchez N, Doolan P, Clarke C, Meleady P, O'Sullivan F, Clynes M: Engineering CHO cell growth and recombinant protein productivity by overexpression of miR-7. J Biotechnol 2011, 151:204-211.
60. Johnson KC, Jacob NM, Nissom PM, Hackl M, Lee LH, Yap M, Hu WS: Conserved microRNAs in Chinese hamster ovary cell lines. Biotechnol Bioeng 2011, 108:475-480.
61. Keasling JD: Manufacturing molecules through metabolic engineering. Science 2010, 330:1355-1358.
62. Curran KA, Alper HS: Expanding the chemical palate of cells by combining systems biology and metabolic engineering. Metab Eng 2012, 14:289-297.
63. Cost GJ, Freyvert Y, Vafiadis A, Santiago Y, Miller JC, Rebar E, Collingwood TN, Snowden A, Gregory PD: BAK and BAX deletion using zinc-finger nucleases yields apoptosis-resistant CHO cells. Biotechnol Bioeng 2009, 105:330-340.
64. Druz A, Chu C, Majors B, Santuary R, Betenbaugh M, Shiloach J: A novel microRNA mmu-miR-466h affects apoptosis regulation in mammalian cells. Biotechnol Bioeng 2011, 108:1651-1661.
65. Koh TC, Lee YY, Chang SQ, Nissom PM: Identification and expression analysis of miRNAs during batch culture of HEK-293 cells. J Biotechnol 2009, 140:149-155.
66. Mulukutla BC, Khan S, Lange A, Hu WS: Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways. Trends Biotechnol 2010, 28:476-484.
67. Chen K, Liu Q, Xie L, Sharp PA, Wang DI: Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody production. Biotechnol Bioeng 2001, 72:55-61. (Pubitemid 32085893)
68. Jeon MK, Yu da Y, Lee GM: Combinatorial engineering of ldh-a and bcl-2 for reducing lactate production and improving cell growth in dihydrofolate reductase-deficient Chinese hamster ovary cells. Appl Microbiol Biotechnol 2011, 92:779-790.
69. Dorai H, Kyung YS, Ellis D, Kinney C, Lin C, Jan D, Moore G, Betenbaugh MJ: Expression of anti-apoptosis genes alters lactate metabolism of Chinese Hamster Ovary cells in culture. Biotechnol Bioeng 2009, 103:592-608.
70. Fan L, Kadura I, Krebs LE, Hatfield CC, Shaw MM, Frye CC: Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells. Biotechnol Bioeng 2012, 109:1007-1015.
71. Dreesen IA, Fussenegger M: Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells. Biotechnol Bioeng 2011, 108:853-866.
72. Baik JY, Gasimli L, Yang B, Datta P, Zhang F, Glass CA, Esko JD, Linhardt RJ, Sharfstein ST: Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin. Metab Eng 2012, 14:81-90.
73. Cornelissen LA, de Vries RP, de Boer-Luijtze EA, Rigter A, Rottier PJ, de Haan CA: A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS ONE 2010, 5:e10645.
74. Bosch BJ, Bodewes R, de Vries RP, Kreijtz JH, Bartelink W, van Amerongen G, Rimmelzwaan GF, de Haan CA, Osterhaus AD, Rottier PJ: Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol 2010, 84:10366-10374.
75. Jacobs PP, Callewaert N: N-Glycosylation engineering of biopharmaceutical expression systems. Curr Mol Med 2009, 9:774-800.
76. Dietmair S, Nielsen LK, Timmins NE: Engineering a mammalian super producer. J Chem Technol Biotechnol 2011, 86:905-914.
77. Daboussi F, Zaslavskiy M, Poirot L, Loperfido M, Gouble A, Guyot V, Leduc S, Galetto R, Grizot S, Oficjalska D et al.: Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases. Nucleic Acids Res 2012, 40:6367-6379.